Toggle Offcanvas
...
 
Lamivudine Tenders

Lamivudine Tenders

View Lamivudine tenders, RFPs and contracts. Bid on readily available Lamivudine tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Lamivudine tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Lamivudine.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Lamivudine market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Lamivudine tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

25 Live Notices for Lamivudine Tenders

Showing 1 to 20

Specific Contract For The Supply Of The Drug “Dolutegravir + Lamivudine 50 Mg/300 Mg”, Required By Asst Santi Paolo E Carlo In Milan, Carried Out Using The Sintel Telematic Platform, Aria2020305 “Dynamic Acquisition System For The Assignment Of Supplies Of Pharmaceutical Products”. Supply Period 12 Months From The Award, With The Option Of Renewal For A Further 6 Months And With An Express Termination Clause In The Event Of Activation Of The Relevant Centralized Agreement By Consip S.P.A. And/Or Aria S.P.A. Cig B57Fbd41E6
country Italy
posting date05 Feb 2025
deadline12 Feb 2025
55Th Generics Tender_Fl
country Germany
posting date05 Feb 2025
deadline17 Mar 2025
Concomitant Use Of Granisetron (Doe), Ondansetron (Doe), Lamivudine (Doe), Lenalidomide (Doe) And Docetaxel (Doe)
country Spain
posting date30 Jan 2025
deadline14 Feb 2025
Framework Agreement With A Single Supplier For The Supply Of Medicines For Hospital Use For The Treatment Of Multiple Sclerosis And Human Immunodeficiency Virus (Hiv) Infection To The Hospitals Of The Extremadura Health Service.
country Spain
posting date24 Jan 2025
deadline24 Feb 2025
Open House Original Discount Agreements 2025-07 - Lamivudine/Abacavir/Dolutegravir (Active Ingredient Combination)
country Germany
posting date22 Jan 2025
deadline28 Feb 2027
Open House Original Discount Agreements 2025-07 - Lamivudine/Abacavir/Dolutegravir (Active Ingredient Combination)
country Germany
posting date22 Jan 2025
deadline28 Feb 2027
Antiretrovirals 2025
country Uruguay
posting date31 Dec 2024
deadline12 Feb 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredients Lamivudine, Tenofovir Disoproxil And Doravirine (J05Ar24) As Part Of A So-Called Open-House Model.
country Germany
posting date17 Apr 2024
deadline31 Mar 2026
Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil And Doravirine, Atc J05Ar24
country Germany
posting date17 Apr 2024
deadline05 Apr 2026
Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil And Doravirine, Atc J05Ar24
country Germany
posting date17 Apr 2024
deadline05 Apr 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredients Lamivudine, Tenofovir Disoproxil And Doravirine (J05Ar24) As Part Of A So-Called Open-House Model.
country Germany
posting date16 Apr 2024
deadline31 Mar 2026
Completion Of A Non-Exclusive Discount Contract According To Section 130C Paragraph 1 Sgb V For Doravirin, Lamivudine, Tenofovir Disoproxil Fumarate, Atc Code: J05Ar24 For The Period From December 1St, 2023 To November 30Th, 2025
country Germany
posting date03 Nov 2023
deadline03 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate, Atc J05Ar24 For The Period December 1St, 2023 - November 30Th, 2025
country Germany
posting date20 Oct 2023
deadline05 Oct 2025
Open House Original Discount Agreements 2023-29 - Dolutegravir/Lamivudine (Combination Of Active Ingredients)
country Germany
posting date13 Sep 2023
deadline31 Oct 2025
Open House Original Discount Contracts 2023-28 - Doravirin, Lamivudine, Tenofovir
country Germany
posting date12 Sep 2023
deadline30 Nov 2025
Open House Original Discount Agreements 2023-29 - Dolutegravir/Lamivudine (Combination Of Active Ingredients)
country Germany
posting date11 Sep 2023
deadline31 Oct 2025
Open House Original Discount Agreements 2023-28 - Doravirine, Lamivudine, Tenofovir
country Germany
posting date09 Sep 2023
deadline30 Nov 2025
Open House Original Discount Contracts 2023-28 - Doravirin, Lamivudine, Tenofovir
country Germany
posting date09 Sep 2023
deadline30 Nov 2025
Completion Of A Non-Excl. Discount Agreement According To § 130C Paragraph 1 Sgb V For Lamivudine And Dolutegravir, Atc Code: J05Ar25 For The Period From September 1St, 2023 To August 31St, 2025
country Germany
posting date09 Aug 2023
deadline04 Jul 2025
Completion Of A Non-Excl. Discount Agreement According To § 130C Paragraph 1 Sgb V For Lamivudine And Dolutegravir, Atc Code: J05Ar25 For The Period From September 1St, 2023 To August 31St, 2025
country Germany
posting date08 Aug 2023
deadline04 Jul 2025

Share Share this page